Supports planned expansion of its ongoing NEXICART-1 NXC-201 CAR-T clinical trial to the U.S.LOS ANGELES, July 10, 2023 Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. , today announced.
LOS ANGELES, July 10, 2023 (GLOBE NEWSWIRE) Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. ("Nexcella", "Company", "We" or "Us"), today announced the completion of its initial CAR-T NXC-201 engineering batch
LOS ANGELES, July 10, 2023 (GLOBE NEWSWIRE) Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. (“Nexcella”, “Company”, “We” or “Us”), today announced the completion of its initial CAR-T NXC-201
Nexcella Completes Initial NXC-201 Engineering Batch at its U S CAR-T Manufacturing Site forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.